Michael Secora, PhD, is a seasoned scientist and investor, currently serving as the Chief Corporate Development Officer and Chief Financial Officer at Iambic Therapeutics. Previously, from 2020 to 2025, they held the role of Chief Financial Officer and Executive Leader of Value Translation at Recursion, where they raised over $1.3 billion and pioneered innovative public engagement strategies. Before Recursion, Michael was the Managing Director and Head of Capital Markets and Venture at Laurion Capital Management LP, focusing on investment strategies in emerging technologies and life sciences. Michael earned a Bachelor of Science in Mathematics and Physics from the Massachusetts Institute of Technology and a PhD in Applied and Computational Mathematics from Princeton University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices